ALKEMY S.P.A. financials
ALKEMY S.P.A.
8156000DFBA84513F952 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €112.0M | €115.0M |
| Gross profit | €5.2M | €11.9M |
| Other income | €3.4M | €4.1M |
| Employee benefits expense | €56.1M | €54.7M |
| Depreciation & amortisation | €4.5M | €4.2M |
| Operating profit (EBIT) | -€12.9M | €6.9M |
| Finance costs | €2.9M | €3.2M |
| Profit before tax | -€15.0M | €4.8M |
| Income tax expense | -€238.0K | €1.3M |
| Profit for the year | -€14.7M | €3.5M |
| — attributable to owners | -€14.8M | €3.5M |
| — attributable to NCI | €27.0K | €72.0K |
| Total comprehensive income | -€14.8M | €3.7M |
| Per share | ||
| Basic EPS | €-2.62 | €0.63 |
| Diluted EPS | €-2.62 | €0.63 |
| Cash flow statement | ||
| Cash generated from operations | €12.4M | €11.3M |
| Net cash from operating activities | €10.6M | €9.2M |
| Net cash from investing activities | -€2.9M | -€1.8M |
| Net cash from financing activities | -€9.0M | -€4.5M |
| Lease liability payments | €2.3M | €2.0M |
| Balance sheet | ||
| Total assets | €111.1M | €130.3M |
| Non-current assets | €56.4M | €67.5M |
| Property, plant & equipment | €1.9M | €1.9M |
| Intangible assets & goodwill | €42.8M | €54.9M |
| Current assets | €54.7M | €62.8M |
| Trade & other receivables | €39.9M | €45.9M |
| Cash & equivalents | €10.7M | €12.0M |
| Total equity | €33.2M | €47.7M |
| — attributable to owners | €32.7M | €47.2M |
| Non-controlling interests | €500.0K | €473.0K |
| Non-current liabilities | €27.7M | €32.6M |
| Lease liabilities (non-current) | €3.5M | €4.4M |
| Current liabilities | €50.3M | €50.0M |
| Lease liabilities (current) | €2.1M | €2.1M |
| Deferred tax liabilities | €19.0K | €18.0K |
| Derived metrics | ||
| Operating margin | -11.6% | 6.0% |
| Net margin | -13.2% | 3.1% |
| Return on equity | -44.4% | 7.4% |
| Cash conversion ratio | -0.72× | 2.60× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | €0 | €0 |
| Adjustments For Decrease Increase In Other Assets | €45.0K | -€791.0K |
| Adjustments For Decrease Increase In Trade Account Receivable | €4.6M | -€5.0M |
| Adjustments For Depreciation and Amortisation Expense | €4.5M | €4.2M |
| Adjustments For Finance Costs | €2.9M | €3.2M |
| Adjustments For Finance Income | €865.0K | €1.1M |
| Adjustments For Income Tax Expense | -€238.0K | €1.3M |
| Adjustments For Increase Decrease In Other Liabilities | -€1.1M | €5.2M |
| Adjustments For Increase Decrease In Trade Account Payable | €1.7M | €76.0K |
| Adjustments For Sharebased Payments | €1.8M | €212.0K |
| Comprehensive Income Attributable To Noncontrolling Interests | €27.0K | €72.0K |
| Comprehensive Income Attributable To Owners of Parent | -€14.8M | €3.6M |
| Current Financial Assets | €26.0K | €107.0K |
| Current Financial Liabilities | €11.3M | €11.6M |
| Current Tax Assets Current | €1.6M | €2.3M |
| Current Tax Liabilities Current | €2.2M | €3.2M |
| Deferred Tax Assets | €2.8M | €1.8M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €0 | €1.3M |
| Dividends Recognised As Distributions To Noncontrolling Interests | €0 | €0 |
| Equity and Liabilities | €111.1M | €130.3M |
| Finance Income | €865.0K | €1.1M |
| Gains Losses On Exchange Differences On Translation Net of Tax | -€76.0K | €96.0K |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €13.7M | €839.0K |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | -€2.0K | €28.0K |
| Income Taxes Paid Refund Classified As Operating Activities | €686.0K | €1.3M |
| Increase Decrease In Cash and Cash Equivalents | -€1.3M | €2.9M |
| Increase Decrease In Financial Assets | €81.0K | €208.0K |
| Increase Decrease Through Sharebased Payment Transactions | -€1.2M | -€46.0K |
| Increase Decrease Through Transfers and Other Changes Equity | €2.0K | €7.0K |
| Intangible Assets Other Than Goodwill | €3.0M | €2.1M |
| Interest Paid Classified As Operating Activities | €1.2M | €838.0K |
| Issued Capital | €596.0K | €596.0K |
| Liabilities | €78.0M | €82.6M |
| Noncurrent Financial Liabilities | €9.8M | €12.0M |
| Noncurrent Provisions | €22.0K | €107.0K |
| Noncurrent Provisions For Employee Benefits | €7.1M | €6.5M |
| Other Adjustments For Noncash Items | €208.0K | -€246.0K |
| Other Comprehensive Income | -€84.0K | €183.0K |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€10.0K | €115.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€76.0K | €96.0K |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€8.0K | €87.0K |
| Other Current Assets | €2.4M | €2.5M |
| Other Current Liabilities | €14.1M | €12.7M |
| Other Income Expense From Subsidiaries Jointly Controlled Entities and Associates | €0 | €0 |
| Other Inflows Outflows of Cash Classified As Financing Activities | €0 | €0 |
| Other Noncurrent Assets | €595.0K | €295.0K |
| Other Noncurrent Financial Assets | €33.0K | €245.0K |
| Other Noncurrent Financial Liabilities | €30.0K | €0 |
| Payments To Acquire Or Redeem Entitys Shares | €43.0K | €120.0K |
| Proceeds From Issuing Shares | €0 | €0 |
| Purchase of Treasury Shares | €43.0K | €120.0K |
| Revenue and Operating Income | €115.3M | €119.2M |
| Rightofuse Assets That Do Not Meet Definition of Investment Property | €5.4M | €6.3M |
| Trade and Other Current Payables To Trade Suppliers | €18.0M | €16.2M |
Every line item above is a fact tagged in ALKEMY S.P.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.